These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31331991)

  • 1. Un-JAMming atherosclerotic arteries: JAM-L as a target to attenuate plaque development.
    Sokeechand BSH; Trigatti BL
    Clin Sci (Lond); 2019 Jul; 133(14):1581-1585. PubMed ID: 31331991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of junctional adhesion molecule-like protein attenuates atherogenesis and enhances plaque stability in ApoE
    Sun Y; Guan J; Hou Y; Xue F; Huang W; Zhang W; Zhang Y; Zhang C; Yang J
    Clin Sci (Lond); 2019 Jun; 133(11):1215-1228. PubMed ID: 31101724
    [No Abstract]   [Full Text] [Related]  

  • 3. Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques.
    Bradfield PF; Menon A; Miljkovic-Licina M; Lee BP; Fischer N; Fish RJ; Kwak B; Fisher EA; Imhof BA
    PLoS One; 2016; 11(7):e0159679. PubMed ID: 27442505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis.
    Fenyo IM; Gafencu AV
    Immunobiology; 2013 Nov; 218(11):1376-84. PubMed ID: 23886694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipin-1 contributes to modified low-density lipoprotein-elicited macrophage pro-inflammatory responses.
    Navratil AR; Vozenilek AE; Cardelli JA; Green JM; Thomas MJ; Sorci-Thomas MG; Orr AW; Woolard MD
    Atherosclerosis; 2015 Oct; 242(2):424-32. PubMed ID: 26288136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
    Cipriani S; Francisci D; Mencarelli A; Renga B; Schiaroli E; D'Amore C; Baldelli F; Fiorucci S
    Circulation; 2013 May; 127(21):2114-24. PubMed ID: 23633271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice.
    Singla DK; Singla R; Wang J
    PLoS One; 2016; 11(1):e0147897. PubMed ID: 26824441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.
    Sato K; Shirai R; Yamaguchi M; Yamashita T; Shibata K; Okano T; Mori Y; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
    Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment.
    Keiper T; Al-Fakhri N; Chavakis E; Athanasopoulos AN; Isermann B; Herzog S; Saffrich R; Hersemeyer K; Bohle RM; Haendeler J; Preissner KT; Santoso S; Chavakis T
    FASEB J; 2005 Dec; 19(14):2078-80. PubMed ID: 16195363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.
    Fraga-Silva RA; Montecucco F; Costa-Fraga FP; Nencioni A; Caffa I; Bragina ME; Mach F; Raizada MK; Santos RAS; da Silva RF; Stergiopulos N
    Vascul Pharmacol; 2015 Nov; 74():103-113. PubMed ID: 26304699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.